Marks Group Wealth Management’s Protolabs PRLB Stock Holding History

Marks Group Wealth Management’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Buy	13,991 +1,939	+16%	+$136K	0.1%	191
2026 Q1	$687K	Hold	12,052	–	–	0.07%	215
2025 Q4	$610K	Hold	12,052	–	–	0.06%	227
2025 Q3	$603K	Hold	12,052	–	–	0.06%	214
2025 Q2	$483K	Hold	12,052	–	–	0.04%	227
2025 Q1	$422K	Hold	12,052	–	–	0.04%	253
2024 Q4	$471K	Hold	12,052	–	–	0.05%	226
2024 Q3	$354K	Sell	12,052 -300	-2%	-$9.15K	0.03%	245
2024 Q2	$382K	Hold	12,352	–	–	0.04%	236
2024 Q1	$442K	Hold	12,352	–	–	0.05%	229
2023 Q4	$481K	Hold	12,352	–	–	0.05%	220
2023 Q3	$326K	Hold	12,352	–	–	0.04%	237
2023 Q2	$432K	Hold	12,352	–	–	0.05%	219
2023 Q1	$409K	Hold	12,352	–	–	0.05%	222
2022 Q4	$315K	Hold	12,352	–	–	0.04%	243
2022 Q3	$450K	Hold	12,352	–	–	0.07%	209
2022 Q2	$591K	Hold	12,352	–	–	0.09%	199
2022 Q1	$653K	Hold	12,352	–	–	0.08%	205
2021 Q4	$634K	Buy	12,352 +1,620	+15%	+$95.6K	0.08%	211
2021 Q3	$714K	Buy	+10,732	New	+$838K	0.1%	178

Other funds holding PRLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Marks Group Wealth Management's PRLB Position: Q2 2026 in Review

Marks Group Wealth Management increased its Protolabs (PRLB) stake by 16% in Q2 2026, buying an estimated $136K and bringing the position to 13,991 shares worth $1.14M. The position accounts for 0.1% of the portfolio, ranked #191.

Marks Group Wealth Management first reported a position in PRLB in Q3 2021 and has held it in 20 quarters since. 278 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

Marks Group Wealth Management held 13,991 shares of Protolabs worth $1.14M as of Q2 2026.
Marks Group Wealth Management bought 1,939 Protolabs shares in Q2 2026, an estimated $136K.
Protolabs made up 0.1% of Marks Group Wealth Management's portfolio in Q2 2026, its #191 holding.
Marks Group Wealth Management first reported a position in Protolabs in Q3 2021 and has held it in 20 quarters since.
278 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on Marks Group Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.